| P2093 | author name string | Macdonald J Christie | |
| | Sarasa Mohammadi | |
| P2860 | cites work | The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1. | Q42687452 |
| | Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice | Q43109150 |
| | Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain | Q43157456 |
| | Modulation of inhibitory synaptic activity by a non-alpha4beta2, non-alpha7 subtype of nicotinic receptors in the substantia gelatinosa of adult rat spinal cord | Q44266707 |
| | Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system | Q44340267 |
| | A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. | Q44461352 |
| | Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. | Q45008678 |
| | A conus peptide blocks nicotinic receptors of unmyelinated axons in human nerves | Q46381570 |
| | Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones | Q46718997 |
| | Sciatic nerve cuffing in mice: a model of sustained neuropathic pain | Q46897992 |
| | Mass Spectral Identification of Vc1.1 and Differential Distribution of Conopeptides in the Venom Duct of Conus victoriae. Effect of Post-Translational Modifications and Disulfide Isomerisation on Bioactivity | Q57053733 |
| | Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain | Q57503507 |
| | Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain | Q60695366 |
| | The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain | Q60695372 |
| | Are 9 10 Nicotinic Acetylcholine Receptors a Pain Target for -Conotoxins? | Q60695375 |
| | Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations | Q71676080 |
| | Novel classes of responsive and unresponsive C nociceptors in human skin | Q72413396 |
| | Adverse effects associated with the intrathecal administration of ziconotide | Q73487816 |
| | A method for measurement of analgesic activity on inflamed tissue | Q74635203 |
| | Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro | Q82828247 |
| | Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors | Q24673308 |
| | Chronic pain epidemiology and its clinical relevance | Q26824123 |
| | Conus venom peptide pharmacology | Q27003318 |
| | Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells | Q28576034 |
| | Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons | Q28578187 |
| | α-conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement | Q30402093 |
| | The nicotinic receptor of cochlear hair cells: a possible pharmacotherapeutic target? | Q30479273 |
| | Inner ear drug delivery for auditory applications | Q30484636 |
| | Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells | Q33720833 |
| | Modulators of nicotinic acetylcholine receptors as analgesics. | Q33976207 |
| | Naturally occurring variants of human Α9 nicotinic receptor differentially affect bronchial cell proliferation and transformation | Q34085848 |
| | Functional characterization of alpha9-containing cholinergic nicotinic receptors in the rat adrenal medulla: implication in stress-induced functional plasticity. | Q34363713 |
| | Neuronal nicotinic receptors as analgesic targets: it's a winding road | Q34364181 |
| | Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes | Q34365845 |
| | Chronic pain, chronic stress and depression: coincidence or consequence? | Q34448514 |
| | Diversity of vertebrate nicotinic acetylcholine receptors | Q34812497 |
| | The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic | Q35547518 |
| | Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats | Q35853738 |
| | γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins | Q36078883 |
| | Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels | Q36159142 |
| | Stress-induced hyperalgesia: animal models and putative mechanisms | Q36486572 |
| | Two distinct channels mediated by m2mAChR and α9nAChR co-exist in type II vestibular hair cells of guinea pig. | Q36913500 |
| | Dilemmas in chronic/persistent pain management | Q37170239 |
| | Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain | Q37312874 |
| | Alpha9 nicotinic acetylcholine receptors and the treatment of pain | Q37336577 |
| | Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor | Q37339057 |
| | Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors. | Q37348886 |
| | Ziconotide for treatment of severe chronic pain | Q37736046 |
| | The prevalence of chronic pain with an analysis of countries with a Human Development Index less than 0.9: a systematic review without meta-analysis | Q38018634 |
| | A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain | Q39278993 |
| | Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial | Q39386029 |
| P304 | page(s) | 64 | |
| P577 | publication date | 2014-10-02 | |
| P1433 | published in | Molecular Pain | Q15766244 |
| P1476 | title | α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia | |
| P478 | volume | 10 | |